» Articles » PMID: 24929140

Risk of Chronic and End Stage Kidney Disease in Patients with Nephrolithiasis

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2014 Jun 15
PMID 24929140
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We examine kidney stone disease as a potential risk factor for chronic kidney disease, end stage kidney disease and treatment with dialysis.

Materials And Methods: The NHANES (National Health and Nutrition Examination Survey) 2007-2010 database was interrogated for patients with a history of kidney stones. Demographics and comorbid conditions including age, gender, body mass index, diabetes, hemoglobin A1c, hypertension, gout and smoking were also assessed. Multivariate analysis adjusting for patient demographics and comorbidities was performed to assess differences in the prevalence of chronic kidney disease and treatment with dialysis between the 2 groups. History of nephrolithiasis was assessed with the question, "Have you ever had kidney stones?" Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml/minute/1.73 m(2) and/or a urinary albumin-to-creatinine ratio greater than 30 mg/gm. Statistical calculations were performed using Stata® software with determinations of p values and 95% CI where appropriate.

Results: The study included an analysis of 5,971 NHANES participants for whom data on chronic kidney disease and kidney stones were available, of whom 521 reported a history of kidney stones. On multivariate analysis a history of kidney stones was associated with chronic kidney disease and treatment with dialysis (OR 1.50, 1.10-2.04, p = 0.013 and OR 2.37, 1.13-4.96, p = 0.025, respectively). This difference appeared to be driven by women, where a history of kidney stones was associated with a higher prevalence of chronic kidney disease (OR 1.76, 1.13-2.763, p = 0.016) and treatment with dialysis (OR 3.26, 1.48-7.16, p = 0.004). There was not a significant association between kidney stone history and chronic kidney disease or treatment with dialysis in men.

Conclusions: Kidney stone history is associated with an increased risk of chronic kidney disease and treatment with dialysis among women even after adjusting for comorbid conditions. Large scale prospective studies are needed to further characterize the relationship between nephrolithiasis and chronic kidney disease.

Citing Articles

Trends in the burden of urolithiasis in China: an analysis from the global burden of disease study 2021.

Lin Y, Lin Q, Zhou Q, Xu N, Zheng D, Wang X Front Surg. 2025; 12:1537706.

PMID: 40040815 PMC: 11876551. DOI: 10.3389/fsurg.2025.1537706.


An analysis of the burden of urolithiasis: differences between the global, China, India and the United States, with projections through 2050.

Han S, Zhao S, Zhong R, Liu H, Liu L, Yan Y Urolithiasis. 2025; 53(1):32.

PMID: 39954073 DOI: 10.1007/s00240-025-01695-3.


Association of tea consumption with all-cause/cardiovascular disease mortality in the chronic kidney disease population: an assessment of participation in the national cohort.

Li J, Chen X, Ou-Yang X, Zhang X, Li Y, Sun S Ren Fail. 2025; 47(1):2449578.

PMID: 39806767 PMC: 11734394. DOI: 10.1080/0886022X.2025.2449578.


Prolyl hydroxylase domain inhibitors prevent kidney crystal formation by suppressing inflammation.

Kawase K, Hamamoto S, Unno R, Taguchi K, Okada A, Yasui T Urolithiasis. 2024; 53(1):16.

PMID: 39724472 DOI: 10.1007/s00240-024-01677-x.


Impact of diet on renal stone formation.

Ghoneim S, Alghaythee H, Alasmari B, Safdar O J Family Med Prim Care. 2024; 13(11):4800-4809.

PMID: 39722982 PMC: 11668459. DOI: 10.4103/jfmpc.jfmpc_770_24.